The 9th U.S. Circuit Court of Appeals has denied requests to rehear its decision vacating registrations for Xtendimax, FeXapan and Engenia, leaving the Supreme Court as the last stop for dicamba manufacturers seeking to overturn the ruling.
Your Agri-Pulse trial will expire in less than two weeks.
To continue receiving full access to Agri-Pulse reporting, newsletters, podcasts and subscriber-exclusive content, visit our subscription page to choose a monthly or annual membership plan.
Questions about pricing or eligibility for discounted rates? Email paige@agri-pulse.com.